Journal
Hematology
Volume 20, Issue 4, Pages 187-195Publisher
MANEY PUBLISHING
DOI: 10.1179/1607845414Y.0000000186
Keywords
Costimulatory molecule; B7-H3; Acute myeloid leukemia; Acute lymphocytic leukemia; Prognosis
Categories
Funding
- National Natural Science Foundation of China [81070456, 81270652]
Ask authors/readers for more resources
Objectives: This study focused on the expression pattern and clinical significance of B7-H3 expression in human acute leukemia. Methods: We systematically analyzed 134 patients with acute myeloid leukemia (101 cases) and acute lymphocytic leukemia (33 cases) by flow cytometry. Results: The frequency of B7-H3(+) cases was 44.8% in total. The B7-H3 expression rate differed from 0% to 74.8% in individual cases. The correlation between B7-H3 expression and traditional prognostic factors, such as age and gender, the white blood cell count was not confirmed. However, B7-H3 had a significant higher expression in CD34(+) cases and high risk karyotypes. Conclusions: Owing to the expression of B7-H3 being statistically relevant in predicting disease progression and a shorter life survival, our results demonstrated that B7-H3 expression in acute leukemia predicts an unfavorable outcome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available